Received May 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | SC |
She is 47 years old and yesterday, 04-May-2025, she received priorix subcutaneously; This non-serious case was reported by a consumer via call center representative and described the occurrence of inappropriate age at vaccine administration in a 47-year-old female patient who received MMR (Priorix) for prophylaxis. On 04-MAY-2025, the patient received Priorix (subcutaneous). On 04-MAY-2025, an unknown time after receiving Priorix, the patient experienced inappropriate age at vaccine administration (Verbatim: She is 47 years old and yesterday, 04-May-2025, she received priorix subcutaneously). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 05-MAY-2025 The reporter was the husband. The patient was the reporter's wife, and She was 47 years old. The reporter did not want to share her exact date of birth or her MD contact information. He did give permission for GSK to contact him via letter but did not want to provide his email address. Consumer reported that yesterday, 04-May-2025, she received Priorix subcutaneously, which led to Inappropriate age at vaccine administration. Reporter did not have access to the lot number because the paperwork she was given did not include the lot number. The reporter was not certain if his wife had prior MMR injections in the past as a child; he assumes that she did. However, she was going to be traveling internationally soon and so it was recommended she receive a Priorix dose prior to travel.; Sender's Comments: US-GSK-US2025055147:same reporter,different patient 1 of 2 report